Ranking Profile - Genocea Biosciences, Inc.

Introduction

Genocea Biosciences Inc (Genocea), formerly Genocea Inc is a biopharmaceutical company. It develops targeted vaccines and immunotherapies for the treatment of cancer. The company’s pipeline products include Gen-009 and Gen-010, a neoantigen cancer vaccine; Gen-011 is an adoptive T cell therapy. It utilizes ATLAS technology platform that identify immunotherapy targets based on tumor antigen-specific T cell responses. The company develops neoantigen cancer vaccines, general cancer vaccines, and a vaccine targeting cancers caused by epstein-barr virus using its technology platform. Genocea is headquartered in Cambridge, Massachusetts, the US.